Bacitracin

DEA Class; Rx

Common Brand Names; BACiiM, Baciguent, Bacitracin Ophthalmic Ointment

• Antibiotics, Other

Ophthalmic, parenteral, and topical polypeptide antibiotic
Used for superficial ocular infections involving the conjunctiva and/or cornea, infants with pneumonia and empyema due to susceptible staphylococci, and infection prevention in minor cuts, scrapes, or burns
Active mainly against gram-positive bacteria

Indicated for the prevention of skin and skin structure infections after a minor compromise in skin integrity such as minor burns or skin abrasion.

Hypersensitivity

• Nephrotoxic reactions including albuminuria, cylindruria, and azotemia
• Nausea and vomiting
• Itching
• Nausea/vomiting
• Blood dyscrasias
• Diaphoresis
• Pain at injection site
• Rash
• Itching
• Pain
• Hypersensitivity reaction (rare)

Do not administer IV; severe thrombophlebitis could occur

Prescribing in absence of proven or strongly suspected bacterial infection or prophylactic indication may not benefit patient and increases development of bacterial resistance

Maintain adequate fluid intake

Antibiotics may cause overgrowth of nonsusceptible organisms, including fungi

Pregnancy Category: C

Lactation: Unknown whether distributed in breast milk

Bacitracin 

ointment

• 500unit/g

ointment

• 500 unit/g (3.5 g)